Javascript must be enabled to continue!
Concomitant CABG vs. CABG Alone - A Comparative Analysis of Early Outcomes
View through CrossRef
Concomitant CABG is performed in combination with other cardiac procedures (VHD, CHD) while CABG is performed exclusively for CAD. Objective: To compare the mortality and perioperative outcomes between CABG and concomitant CABG for proper quoting of risk & optimizing the treatment decision for improved patient outcomes. Methods: The observational study on retrospective data was conducted at Rehman Medical Institute from December 2020 to December 2022. A total of 169 patients were included, with 89 in the CABG and 80 in the concomitant CABG group. Ethical approval was granted and inclusion criteria were met. Data were analyzed using SPSS 25. Results: A total of 169 patients were included with a mean age of 57.72±10.65 & the majority of the male population (77.5%). Most of the patients had NYHA III (56.1%) & CCS III (43.9%) class symptoms. Hypertension was our most common co-morbidity (58.0%), followed by dyslipidemia (52.3%) & DM (47.3%). Concomitant CABG has the worst parameters in terms of intraoperative characteristics such as a statistically significant higher rate of intraoperative transfusion (p <0.001), prolonged perfusion (p <0.001) & cross-clamp time (p<0.001). Similarly, concomitant CABG patients have the worst postoperative outcomes with a significantly higher incidence of mortality (p <0.001), post-operative transfusion requirement (p 0.008), increased duration of mechanical ventilation hours (p 0.005), extended hours of ICU stay (p 0.02) & higher rates of re-intubation (p 0.03). Conclusions: Concomitant CABG is no doubt a high-risk procedure as signified by its worst outcomes.
CrossLinks International Publishers
Title: Concomitant CABG vs. CABG Alone - A Comparative Analysis of Early Outcomes
Description:
Concomitant CABG is performed in combination with other cardiac procedures (VHD, CHD) while CABG is performed exclusively for CAD.
Objective: To compare the mortality and perioperative outcomes between CABG and concomitant CABG for proper quoting of risk & optimizing the treatment decision for improved patient outcomes.
Methods: The observational study on retrospective data was conducted at Rehman Medical Institute from December 2020 to December 2022.
A total of 169 patients were included, with 89 in the CABG and 80 in the concomitant CABG group.
Ethical approval was granted and inclusion criteria were met.
Data were analyzed using SPSS 25.
Results: A total of 169 patients were included with a mean age of 57.
72±10.
65 & the majority of the male population (77.
5%).
Most of the patients had NYHA III (56.
1%) & CCS III (43.
9%) class symptoms.
Hypertension was our most common co-morbidity (58.
0%), followed by dyslipidemia (52.
3%) & DM (47.
3%).
Concomitant CABG has the worst parameters in terms of intraoperative characteristics such as a statistically significant higher rate of intraoperative transfusion (p <0.
001), prolonged perfusion (p <0.
001) & cross-clamp time (p<0.
001).
Similarly, concomitant CABG patients have the worst postoperative outcomes with a significantly higher incidence of mortality (p <0.
001), post-operative transfusion requirement (p 0.
008), increased duration of mechanical ventilation hours (p 0.
005), extended hours of ICU stay (p 0.
02) & higher rates of re-intubation (p 0.
03).
Conclusions: Concomitant CABG is no doubt a high-risk procedure as signified by its worst outcomes.
Related Results
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Protocol for a retrospective, comparative effectiveness study of the association between transesophageal echocardiography (TEE) monitoring used in coronary artery bypass graft (CABG) surgery and clinical outcomes
Protocol for a retrospective, comparative effectiveness study of the association between transesophageal echocardiography (TEE) monitoring used in coronary artery bypass graft (CABG) surgery and clinical outcomes
AbstractBackgroundCoronary artery bypass graft (CABG) surgery is the most widely performed adult cardiac surgery in the US. Transesophageal echocardiography (TEE) is an ultrasound-...
Determinants of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis
Determinants of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis
Introduction: Coronary Artery Bypass Graft (CABG) surgery has potential benefits for patients with Coronary Artery Disease (CAD). The consensus associated with Percutaneous Coronar...
e0278 Investigation of repeat coronary revascularization in Beijing Anzhen Hospital
e0278 Investigation of repeat coronary revascularization in Beijing Anzhen Hospital
Objectives
Although data of prevalence of prior percutaneous coronary intervention (PCI) and prior coronary artery bypass graft (CABG) are available in the Europe...
Factors associated with return to work after coronary artery bypass grafting (CABG)
Factors associated with return to work after coronary artery bypass grafting (CABG)
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background.
...
Hybrid Revascularizaton vs Conventional CABG in Triple Vessel Disease: Mini Systematic Review
Hybrid Revascularizaton vs Conventional CABG in Triple Vessel Disease: Mini Systematic Review
Background: Hybrid coronary revascularisation (HCR) integrates minimally invasive coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI), presenting a...
Short-term outcomes of on- vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis
Short-term outcomes of on- vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis
Abstract
Objectives
Does the manipulation of the off-pump CABG (OPCAB) in patient with depressed left ventricular function is better than on-pump CA...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

